Lucira Health, Inc. (LHDX) Misses Q3 EPS by 277c

Lucira Health, Inc. (NASDAQ: LHDX) reported Q3 EPS of ($3.15), $2.77 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $34.4 million versus the consensus estimate of $33.33 million.

For earnings history and earnings-related data on Lucira Health, Inc. (LHDX) click here.

You May Also Be Interested In

• Burry doubles down on Nebius short after stock surges 34% on earnings
• Lucid Diagnostics Inc. (LUCD) Reports In-Line Q2 EPS
• NextPlat Corp (NXPL) Reports Q2 Loss of $0.05